Home

Insights

PE

Vanta Bioscience Ltd P/E Ratio

Vanta Bioscience Ltd P/E Ratio

download
stocks purchased

₹ 0.0 Cr

Volume transacted

stocks purchased

7.5 K

stocks traded

Last Updated time: 13 Jul 10:55 AM

Image

Vanta Bioscience Ltd

NSE: VANTABIOSCIENCE

PE

0

Last updated : 13 Jul 10:55 AM

Key Highlights

    The P/E Ratio of Vanta Bioscience Ltd is 0 as of 13 Jul 10:55 AM .a1#The P/E Ratio of Vanta Bioscience Ltd changed from 137.8 on March 2019 to 0 on March 2023 . This represents a CAGR of -100.00% over 5 years. a1#The Latest Trading Price of Vanta Bioscience Ltd is ₹ 53.76 as of 11 Jul 15:30 .a1#The PE Ratio of Miscellaneous Industry has changed from 158.5 to 149.7 in 5 years. This represents a CAGR of -1.14%a1# The PE Ratio of Automobile industry is 17.2. The PE Ratio of Finance industry is 24.7. The PE Ratio of IT - Software industry is 29.2. The PE Ratio of Miscellaneous industry is 28.4. The PE Ratio of Retail industry is 143.1. The PE Ratio of Textiles industry is 12.1. In 2024a1#The Market Cap of Vanta Bioscience Ltd changed from ₹ 96.54 crore on March 2019 to ₹ 36.29 crore on March 2023 . This represents a CAGR of -17.77% over 5 years. a1#The Revenue of Vanta Bioscience Ltd changed from ₹ 2.83 crore to ₹ 4.13 crore over 2 quarters. This represents a CAGR of 112.97% a1#The EBITDA of Vanta Bioscience Ltd changed from ₹ -0.54 crore to ₹ -1.17 crore over 2 quarters. This represents a CAGR of 369.44% a1#The Net Pr of Vanta Bioscience Ltd changed from ₹ -2.56 crore to ₹ -3.92 crore over 2 quarters. This represents a CAGR of 134.47% a1#The Dividend Payout of Vanta Bioscience Ltd changed from 0 % on March 2019 to 0 % on March 2023 . This represents a CAGR of 0.0% over 5 years. a1#

Open Demat Account

Lead form image

Enter your mobile no. to continue

+91

*By signing up you agree to our terms & conditions

50 Years

of Trust & Legacy

₹0 AMC

for First Year

₹0 Brokerage

on Delivery, Intraday, Currency and NSE F&O

×

Historical P/E Ratio of Vanta Bioscience Ltd

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Historical P/E Ratio of Vanta Bioscience Ltd

Period
Mar '19137.8
Mar '2057.2
Mar '21229.6
Mar '22784.6
Mar '230

Company Fundamentals for Vanta Bioscience Ltd

Market Cap

33 Cr

EPS

0.0

P/E Ratio (TTM) *

0.0

P/B Ratio (TTM) *

1.9

Day’s High

58.92

Day’s Low

53.68

DTE *

3.4

ROE *

-26.2

52 Week High

101.64

52 Week Low

37.0

ROCE *

-2.7

* All values are consolidated

Last Updated time: 13 Jul 10:55 AM

* All values are consolidated

Last Updated time: 13 Jul 10:55 AM

Image

Vanta Bioscience Ltd

NSE: VANTABIOSCIENCE

PRICE

53.76

-2.74 (-4.85%)

stock direction

Last updated : 11 Jul 15:30

×

PRICE

The current market price or CMP refers to the price at which the securities are trading in the share market. Current price in Over-the-counter costs: The following current price depends upon the bid price & the asking price when a financial asset is sold over-the-counter(OTC). Current Price in Bond Market: The current price of a bond is determined by measuring the actual interest rate against the bid-related interest rate. The par or the face value is then calculated to represent the remaining interest payments due which occur before the maturity of the bond.

Share price Over Time

1M

1Y

3Y

5Y

* All values are in Rupees

Asset Value vs Market Value of Vanta Bioscience Ltd

Market Value

34

Asset Value

15

1.2 X

Value addition

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Vanta Bioscience Ltd033
Godrej Agrovet Ltd4415,911
Indegene Ltd4214,103
Thomas Cook (India) Ltd4511,885
RattanIndia Enterprises Ltd2310,912
CMS Info Systems Ltd258,679

Key Valuation Metric of Vanta Bioscience Ltd

Earnings

-6 Cr

0.0 X

PE Ratio

Market Cap

₹33.93Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

Earnings

-6 Cr

0.0 X

PE Ratio

Market Cap

₹33.93Cr

PE Ratio

PS Ratio

PB Ratio

The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share.


P/E Ratio Formula


P/E ratio = (CMP of share/ Earning per share)


Types of Price to Earning Ratio


1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance.
2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.

PE Ratio of Miscellaneous Industry over time

PE Ratio of Top Sectors

×

Historical Market Cap of Vanta Bioscience Ltd

Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore

Historical Market Cap of Vanta Bioscience Ltd

Period
Mar '1997
Mar '2057
Mar '21103
Mar '2269
Mar '2336

* All values are a in crore

×

Historical Revenue of Vanta Bioscience Ltd

Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services. Types of Revenue: 1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered. 2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees. Formula for Revenue: The formula for calculating revenue is based on two goods & services: For goods: Revenue = Avg unit price x Number of Units sold For services: Revenue = Avg unit price x Number of Customers served.

Historical Revenue of Vanta Bioscience Ltd

Period
Dec '223
Mar '234

* All values are a in crore

×

Historical EBITDA of Vanta Bioscience Ltd

PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.

Historical EBITDA of Vanta Bioscience Ltd

Period
Dec '22-1
Mar '23-1

* All values are a in crore

×

Historical Net Profit of Vanta Bioscience Ltd

Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions. Net Profit formula is expressed as: Net Profit = Total Revenue - Total Expense Net Profit Margin Ratio: Net Profit Margin Ratio = Net Profit / Total Revenue

Historical Net Profit of Vanta Bioscience Ltd

Period
Dec '22-3
Mar '23-4

* All values are a in crore

×

Historical Dividend Payout of Vanta Bioscience Ltd

Dividend payout refers to the total dividends paid to shareholders relative to the company's earnings. It is a financial measure that determines the percentage of earnings paid out to existing shareholders as dividends. How to calculate Dividend Payout Ratio? The dividend payout ratio formula is as follows: DPR = Dividends paid / Net earnings With the dividend payout ratio, you can understand the company's priorities. It is an important metric that allows you to easily check DPR online.

Historical Dividend Payout of Vanta Bioscience Ltd

Period
Mar '190
Mar '200
Mar '210
Mar '220
Mar '230

* All values are a in %

About Vanta Bioscience Ltd

About Vanta Bioscience Ltd

    Vanta Bioscience Limited was originally incorporated as a Private Limited Company on 29th April 2016 with the name 'Vanta Bioscience Private Limited'. The Company converted into a Public Limited Company and the name was changed to 'Vanta Bioscience Limited' on 17th March 2017. The Company is presently engaged in the business of Preclinical Activities. The Company provides risk assessment services for evaluating safety of the Active Pharmaceutical Ingredients (API), excipients, extractable and leachables including pharmaceutical impurities resulting due to manufacturing process or due to degradation of product. The Company is established as a center of excellence for GLP toxicology and safety assessment offering services in India and across the globe. One of the major services of VBS is conducting variety of in vitro (cell, tissue and organisms) and in vivo (animal) toxicology studies for its diverse clients as per various regulatory requirements from across the world. Toxicology is a branch of biology, chemistry, and pharmacology concerned with the study of the adverse effects of chemicals on living organisms. It also studies the harmful effects of chemical, biological and physical agents in biological systems that establish the extent of damage in living organisms. The Company purchased preclinical CRO facility at Gummidipundi, Chennai from Kemin Industries South Asia Private Limited which was named as 'Vanta Bioscience' (a toxicology division and commenced commercial activities in April, 2017. VBS has state of the art facilities and infrastructure necessary for conduct of all kind of toxicology studies for Chemicals, Pharmaceuticals, Cosmetics, Agrochemicals like Pesticides, Insecticides, Excipients, Novel Feed Additives. In addition, the Company conducts preclinical proof-of-concept (PoC) studies for novel pharmaceuticals and products intended for new indications in variety of animal models of human diseases through a robust process of validation. In September 2017, the Company came up with a Public Issue of 15,12,000 Equity Shares by raising money from public aggregating to Rs 7.56 Crore. In 2018-19, Vanta Clinical Research Limited and Vayam Research Solutions Limited became the subsidiaries of the Company.

Vanta Bioscience Ltd News Hub

News

Vanta Bioscience to table results

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 17 July 2...

Read more

11 Jul 202409:47

News

Vanta Bioscience wins order of Rs 1.2 cr

Vanta Bioscience has received an order of Rs. 1.2 crore from a large Indian Multinational ...

Read more

03 Apr 202415:22

News

Vanta Bioscience wins order of Rs 57 lakh

Vanta Bioscience has received order of Rs 57 lakh from a renowned Singapore Company to car...

Read more

02 Dec 202311:47

News

Vanta Bioscience to conduct board meeting

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 14 Novemb...

Read more

09 Nov 202316:17

News

Vanta Bioscience to convene AGM

Vanta Bioscience announced that the 7th Annual General Meeting (AGM) of the company will b...

Read more

16 Sep 202310:34

News

Vanta Bioscience to conduct board meeting

Vanta Bioscience will hold a meeting of the Board of Directors of the Company on 10 August...

Read more

09 Aug 202311:20

Product Composition by Percentage (Revenue)

FAQs for PE of Vanta Bioscience Ltd

What is Vanta Bioscience Ltd current share price?

The current market price of Vanta Bioscience Ltd as of July 13, 2024 is ₹53.76.

What is Vanta Bioscience Ltd's market cap?

Vanta Bioscience Ltd's market capitalisation stood at ₹33 Cr as of July 13, 2024

What are Vanta Bioscience Ltd's total net assets?

According to Vanta Bioscience Ltd's most recent financial filings, the company's net assets total ₹15.2 Cr.

Is Vanta Bioscience Ltd making a profit or loss?

Vanta Bioscience Ltd's net Profit as of July 13, 2024 is close to ₹-6 Cr.
up arrow
50yearstrust

Unlimited trading at just

Rs. 399

Rs. 199